Proactive Bleeding Detection and Personalized Fluid Resuscitation Platform

A next-generation bleeding detection and fluid resuscitation platform that leverages AI, machine learning, and real-time analytics to prevent bleeding before it occurs, and provides personalized, precision-controlled fluid administration for optimal patient outcomes.

The original patent disclosed a method for rapid detection of bleeding before, during, and after fluid resuscitation. However, this approach has limitations, including reliance on retrospective analysis and lack of proactive bleeding prevention. The new inventive concept addresses these limitations by integrating advanced signal processing, machine learning, and real-time analytics to predict bleeding likelihood and trigger preventative measures.

The new inventive concept comprises a wearable sensor array, machine learning-based algorithm, and fluid administration module. The wearable sensor array continuously monitors a patient's physiological data, which is then analyzed by the machine learning-based algorithm to predict bleeding likelihood. The fluid administration module adjusts fluid infusion rates based on the predicted bleeding likelihood, ensuring personalized, precision-controlled fluid administration. Additionally, the platform incorporates advanced signal processing techniques, decentralized data storage, and federated learning frameworks to enable proactive bleeding prevention and real-time model updates.

The new claims introduce a paradigm shift in bleeding detection and fluid resuscitation by integrating AI, machine learning, and real-time analytics to prevent bleeding before it occurs. The inventive concept's proactive approach, leveraging advanced signal processing and machine learning, represents a significant departure from the original patent's retrospective analysis and reactive bleeding detection.

Alternative embodiments of the inventive concept could include a handheld sensor unit, a cloud-based analytics platform, or a decentralized, blockchain-based data storage system. Variations could include integrating the platform with existing medical devices, such as defibrillators or patient monitors, or developing specialized algorithms for specific patient populations, such as pediatric or geriatric patients.

The inventive concept has significant commercial potential in the medical device and healthcare industries, particularly in the areas of critical care, emergency medicine, and patient monitoring. The platform's ability to prevent bleeding and optimize fluid administration could reduce healthcare costs, improve patient outcomes, and enhance the overall quality of care.